Recombinant human CC16 gene, construction of eukaryotic expression vector of CC16 gene, and purification of recombinant protein

A eukaryotic expression vector, CC16 technology, applied in the field of genetic engineering, can solve the problems of decreased airway anti-inflammatory ability and inflammation deterioration

Inactive Publication Date: 2015-05-13
SHANXI MEDICAL UNIV
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The same result was also observed in the rat COPD model prepared by cigarette smoke. It was found that Clara cells and CC16 were significantly reduced when airway inflammation occurred, and the reduction of CC16 would lead to a decrease in the anti-inflammatory ability of the airway, leading to further deterioration of inflammation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant human CC16 gene, construction of eukaryotic expression vector of CC16 gene, and purification of recombinant protein
  • Recombinant human CC16 gene, construction of eukaryotic expression vector of CC16 gene, and purification of recombinant protein
  • Recombinant human CC16 gene, construction of eukaryotic expression vector of CC16 gene, and purification of recombinant protein

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Using the PAS (PCR-based Accurate Snthesis) method, according to the human CC16 protein coding gene (gene accession number: U01101.1), design the recombinant human CC16 gene sequence, synthesize the full-length splicing primers of the gene, and design protection at both ends of the primers Base, GCCACC (Kazak sequence) is added to the 5' end, and 3×Flag tag is added to the 3' end. The gene sequence was synthesized by Nanjing Zhongding Biotechnology Co., Ltd., and the synthesized hCC16 gene has the nucleotide sequence shown in SEQ NO.1.

[0043] Combine pMSCVpuro vector and hCC16 gene sequence with restriction endonuclease xho I and EcoR I double enzyme digestion, agarose gel electrophoresis to separate the digested product. After the digested product was recovered by the gel recovery kit, the digested carrier and digested hCC16 were mixed at a molar ratio of 1:3, and 4 Under the action of DNA ligase, react at 22°C for 1h. Then, the ligated products were transfor...

Embodiment 2

[0047] HEK 293T cells were cultured in DMEM high glucose medium (10% newborn bovine serum, penicillin 100u / ml, streptomycin 100ug / ml) at 37°C and 5% CO 2 Under the conditions of growth, the medium was changed every 3 to 4 days.

[0048] Use a 6cm culture dish for cell transfection. When the cells grow to 80-90% confluent, operate according to the instructions of the transfection reagent, transfect 2 μg of pMSCVpuro-hCC16 plasmid, and transfect the same amount of empty plasmid pMSCVpuro as a control; 48 hours later Cells were collected, protein was extracted with RIPA lysate, and the expression of hCC16 was identified by Western blotting. That is, after the protein extract was quantified by the BCA method, 20 μg of the total protein was taken for 12% SDS-PAGE separation, and then the protein on the gel was transferred to the membrane, blocked and other procedures, respectively, with rabbit anti-human CC16 antibody (1:1000 ), human anti-Flag monoclonal antibody (1:1000) as prim...

Embodiment 3

[0051] Collect the above serum-free medium. The remaining cells were washed with PBS to obtain cells stably transfected with pMSCVpuro-hCC16, and 1.5 ml of protein lysate (50 mM Tris-HCl, pH 7.4; 150 mM NaCl; 1 mM EDTA; 1% TRITON X-100) was added, incubated for 30 min, and used The cell lysate was collected by scraping the cells, centrifuged at 12000 g for 10 min, and the supernatant was collected and placed on ice. At 4°C, add the collected serum-free medium and cell lysate to ANTI-FLAG M pre-balanced with TBS (50mM Tris HCl, 150mM NaCl, pH7.4) 2 For affinity gels, incubate the protein with the gel overnight. The next day, wash off unbound protein with 20 column volumes of TBS. Add 6ml of 0.1M glycine-HCl, pH 3.5, to elute the bound target protein. Add 600 μl of 0.5M Tris HCl, pH7.4; 1.5M NaCl to the eluate, use a concentration tube with a molecular weight cutoff of 3kDa to concentrate the target protein, and adjust the protein concentration to 1 μg / μl. The obtained prote...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a synthesized recombinant human CC16 gene shown as SEQ ID NO.1, construction of a eukaryotic expression recombinant plasmid containing the CC16 gene, and production of purified recombinant human CC16 protein after cell transfection. The obtained recombinant human CC16 protein can inhibit PLA2 activity, so that a condition is created by using the recombinant protein to realize intervention therapy on inflammatory lung diseases.

Description

technical field [0001] The invention belongs to the technical field of genetic engineering, and relates to a human CC16 gene synthesized by DNA recombination technology, the construction of eukaryotic expression recombinant plasmid and the separation and purification of the recombinant protein after expression. Background technique [0002] CC16 protein is mainly secreted by Clara cells, which are non-ciliated columnar epithelial cells on the bronchiole and terminal bronchiole mucosa. Because of its molecular weight of about 15.8kDa, it is called CC16 protein, also known as Clara cell secreted protein (Clara cell secretory protein, CCSP). CC16 is a tissue-specific protein, mainly expressed in lung tissue, accounting for 2% to 3% of soluble protein in human bronchoalveolar lavage fluid (BALF). [0003] Studies have shown that the occurrence of many chronic pulmonary inflammatory diseases is related to the reduction of Clara cells and CC16 content in the lungs, such as chroni...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N15/12C12N15/85C12N5/10C07K14/47C07K1/22
Inventor 庞敏王海龙袁丽荣张新日胡晓芸杜永成
Owner SHANXI MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products